India Meditech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 25-11-2024
- Paid Up Capital ₹ 1.98 Cr
as on 25-11-2024
- Company Age 29 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.19 Cr
as on 25-11-2024
- Revenue -34.49%
(FY 2024)
- Profit -249.39%
(FY 2024)
- Ebitda 10336.26%
(FY 2024)
- Net Worth -1467.60%
(FY 2024)
- Total Assets -18.73%
(FY 2024)
About India Meditech
The Corporate was formerly known as Prasang Steels Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.98 Cr.
The company currently has active open charges totaling ₹10.19 Cr.
Vimal Khemka, Abhishek Khemka, Sanjeev Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999DL1996PTC075408
- Company No.
075408
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at India Meditech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Khemka  | Director | 01-Sep-2024 | Current |
| Vimal Khemka | Director | 21-Jan-2012 | Current |
| Sanjeev Kumar | Additional Director | 03-Jul-2020 | Current |
| Satish Chand | Director | 16-Sep-2024 | Current |
Financial Performance of India Meditech.
India Meditech Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 34.49% decrease. The company also saw a substantial fall in profitability, with a 249.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1467.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of India Meditech?
In 2024, India Meditech had a public holding of 78.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Oct 2020 | ₹3.74 Cr | Open |
State Bank Of India Creation Date: 01 Nov 2014 | ₹5.46 Cr | Open |
State Bank Of India Creation Date: 11 May 2012 | ₹9.88 M | Open |
How Many Employees Work at India Meditech?
India Meditech has a workforce of 17 employees as of Nov 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of India Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped India Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
